Full coverage: Stem cells

Following months of controversy, editors at the scientific journal Nature have retracted two high-profile studies that purported to demonstrate a quick and simple way of making flexible stem cells without destroying embryos or tinkering with DNA.

Scientists replicate a study that produced the world’s first cloned human embryos and used them to make stem cells.

Scientists have taken skin cells from a woman suffering from type 1 diabetes, reprogrammed them into embryonic stem cells, and then converted those cells into insulin-producing cells in mice, according to a new study.

As new revelations further discredit a highly publicized Japanese study on the use of acid to create so-called STAP stem cells, scientists in the U.S. have quietly announced a research breakthrough that involves a more traditional means of producing the amazingly versatile cells.

Scientists trying to use stem cells to grow organs in the lab have been going about it the wrong way, Japanese researchers say.

Researchers have reprogrammed cells inside living mice -- and have discovered that the pluripotent stem cells created in the process are even more flexible than those derived from embryos or grown in laboratory dishes.

In a feat that experts say is a significant advance for regenerative medicine, scientists have discovered a surprisingly simple method for creating personalized stem cells that doesn’t involve human embryos or tinkering with DNA.

The Japanese stem cell scientist who was accused of misconduct by her own research institution apologized Wednesday for making careless mistakes but insisted that her STAP stem cells are real.

Research that made international headlines with a purported breakthrough in the creation of highly valuable stem cells has been found to contain falsified and manipulated data, according to a panel of Japanese investigators.

They had each lost slabs of muscle to bomb blasts or other physical traumas, then struggled to regain even partial function of their mangled legs.

A government official says the technique would make such research eligible for federal funding.

The governing board of the California Institute for Regenerative Medicine announced Wednesday that it was appointing C.